Formosa KRAS Mutation Detection Kit - Taiwan Registration e9e3b1d3a7437e0e181bf9e2500dd9c2
Access comprehensive regulatory information for Formosa KRAS Mutation Detection Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number e9e3b1d3a7437e0e181bf9e2500dd9c2 and manufactured by Formosa Biomedical Technology Co., Ltd. Yilan Factory. The authorized representative in Taiwan is FORMOSA BIOMEDICAL TECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
e9e3b1d3a7437e0e181bf9e2500dd9c2
Ministry of Health Medical Device Manufacturing No. 005818
Product Details
This product is used to detect patients with metastatic colorectal cancer whose tumors carry mutations in the positions of KRAS gene Codon12 and 13, and to screen out patients who can be treated with EGFR monoclonal antibodies. This product is only used for clinical auxiliary diagnosis, and the physician must judge the actual situation of the case when applying it clinically, and cannot use the test results of this product as the only basis. This product is suitable for the specimen of formarin fixed paraffin-embedded tissue.
B Hematology and pathology devices
B4020 Analyze specific reagents
Produced in Taiwan, China
Dates and Status
Feb 21, 2018
Feb 21, 2028